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Cellular/Molecular

Expression of Nampt in Hippocampal and Cortical
Excitatory Neurons Is Critical for Cognitive Function
Liana Roberts Stein,1 David F. Wozniak,2,3 Joshua T. Dearborn,2 Shunsuke Kubota,4 Rajendra S. Apte,1,4
Yukitoshi Izumi,2,3 Charles F. Zorumski,2,5 and Shin-ichiro Imai1
1

Department of Developmental Biology, 2Department of Psychiatry, 3The Taylor Family Institute for Innovative Psychiatric Research, 4Department of
Ophthalmology, and 5Department of Anatomy and Neurobiology, Washington University School of Medicine, St. Louis, Missouri 63110

Nicotinamide adenine dinucleotide (NAD ⫹) is an enzyme cofactor or cosubstrate in many essential biological pathways. To date, the
primary source of neuronal NAD ⫹ has been unclear. NAD ⫹ can be synthesized from several different precursors, among which nicotinamide is the substrate predominantly used in mammals. The rate-limiting step in the NAD ⫹ biosynthetic pathway from nicotinamide is
performed by nicotinamide phosphoribosyltransferase (Nampt). Here, we tested the hypothesis that neurons use intracellular Namptmediated NAD ⫹ biosynthesis by generating and evaluating mice lacking Nampt in forebrain excitatory neurons (CaMKII␣Nampt ⫺ / ⫺
mice). CaMKII␣Nampt ⫺ / ⫺ mice showed hippocampal and cortical atrophy, astrogliosis, microgliosis, and abnormal CA1 dendritic
morphology by 2–3 months of age. Importantly, these histological changes occurred with altered intrahippocampal connectivity and
abnormal behavior; including hyperactivity, some defects in motor skills, memory impairment, and reduced anxiety, but in the absence
of impaired sensory processes or long-term potentiation of the Schaffer collateral pathway. These results clearly demonstrate that
forebrain excitatory neurons mainly use intracellular Nampt-mediated NAD ⫹ biosynthesis to mediate their survival and function.
Studying this particular NAD ⫹ biosynthetic pathway in these neurons provides critical insight into their vulnerability to pathophysiological stimuli and the development of therapeutic and preventive interventions for their preservation.
Key words: CA1; cognition; hippocampus; NAD ⫹; Nampt

Introduction

Nicotinamide adenine dinucleotide (NAD ⫹) is a classic coenzyme used in many critical metabolic pathways such as glycolysis, the tricarboxylic acid cycle, and mitochondrial oxidative
phosphorylation (Hirrlinger and Dringen, 2010). NAD ⫹ is
also required for the synthesis of essential compounds, including most nucleoside triphosphates and some amino acids
(Lunt and Vander Heiden, 2011), and for the enzymatic reactions of poly-ADP-ribose polymerases (PARPs), CD38/
CD157 ectoenzymes, and sirtuins (Stein and Imai, 2012). In
mammals, NAD ⫹ can be synthesized from four precursors:
nicotinamide, nicotinic acid, tryptophan, and nicotinamide
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riboside (Houtkooper et al., 2010; Stein and Imai, 2012).
However, the predominantly used pathway is the conversion
of nicotinamide to NAD ⫹. The rate-limiting step of this pathway is performed by nicotinamide phosphoribosyltransferase
(Nampt; Revollo et al., 2004; Revollo et al., 2007). In mice,
protein expression of Nampt is relatively high in brown adipose tissue, liver, and kidney, but nearly undetectable in the
pancreas and brain (Kitani et al., 2003; Revollo et al., 2007;
Friebe et al., 2011).
Neurons must maintain high rates of oxygen consumption
and ATP synthesis for proper function (Barros and Deitmer,
2010). With such high neuronal metabolic activity, glia play an
important role in the generation and secretion of energy substrates, such as glucose and monocarboxylic acids, to neurons
(Izumi et al., 1997; Pellerin et al., 2007; Barros and Deitmer,
2010; Hirrlinger and Dringen, 2010). However, it has been
poorly understood how neurons obtain sufficient NAD ⫹ to
meet their energetic needs. Although Nampt-mediated NAD ⫹
biosynthesis maintains NAD ⫹ levels in cultured neurons (Pittelli et al., 2010; Wang et al., 2011b), current work has implied
that glia may supply NAD ⫹ to neurons because glia possess
efficient NAD ⫹ biosynthesis machinery, whereas neurons
may not (Verderio et al., 2001; Sasaki et al., 2006). Therefore,
the fact that Nampt is selectively expressed in neurons of the
hippocampus and cortex (Zhang et al., 2010; Wang et al.,
2011b), key brain structures in cognition and emotion (Barkus
et al., 2010), raises an interesting question: is Nampt-mediated
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NAD ⫹ biosynthesis the primary source of NAD ⫹ for forebrain neurons?
We hypothesized that forebrain excitatory neurons depend
upon intracellular Nampt-mediated NAD ⫹ biosynthesis. To test
this hypothesis, we generated CaMKII␣Nampt ⫺ / ⫺ mice by
crossing Nampt flox/flox mice with CaMKII␣Cre transgenic mice.
The CaMKII␣Cre driver mediates recombination in forebrain
excitatory neurons, primarily in the hippocampal cornu ammonis 1 (CA1) subregion and cortical layers II/III. Recombination
begins at postnatal day (P) 14 to P18, plateaus at P28, and spreads
progressively to the CA3 and dentate gyrus (DG) hippocampal
subregions (Tsien et al., 1996; Monteggia et al., 2007; Wang et al.,
2011a). We found that CaMKII␣Nampt ⫺ / ⫺ mice exhibit hyperactivity, impaired learning and memory, and reduced levels of
anxiety-like behaviors. In light of these remarkable phenotypes,
we conclude that forebrain excitatory neurons depend upon
intracellular Nampt-mediated NAD ⫹ biosynthesis and cannot obtain sufficient NAD ⫹ metabolites from other sources
for successful cognitive function. Because CA1 sustains the
most damage in many prevalent diseases and conditions,
CaMKII␣Nampt ⫺ / ⫺ mice provide critical insight into the importance of Nampt-mediated NAD ⫹ biosynthesis for therapeutic/preventive interventions against functional defects in
forebrain excitatory neurons.

Materials and Methods
Animals. Mice were maintained on a regular chow ad libitum diet (PicoLab 5053 Rodent Diet 20; Lab Diets) on a 12 h light/dark cycle (lights
on from 6:00 A.M. to 6:00 P.M.). Parent lines were maintained as
homozygous colonies. Nampt flox/flox mice (Rongvaux et al., 2008)
were crossed to CaMKII␣Cre mice (stock #005359, T29-1; The Jackson Laboratory; Tsien et al., 1996) to generate Namptf lox/⫹;Cre double heterozygous mice. Double heterozygous mice were bred to
Nampt flox/flox mice to obtain Nampt flox/flox;Cre (CaMKII␣Nampt ⫺ / ⫺)
mice. CaMKII␣Nampt ⫺ / ⫺ mice were obtained in the expected Mendelian ratio. In all experiments, “control” mice were age-matched littermates. The CaMKII␣Cre driver mice were generated from 8.5 kb
genomic DNA fragment derived from the CaMKII␣ gene (Tsien et al.,
1996). All animal procedures were approved by the Washington University Animal Studies Committee and were in accordance with National
Institutes of Health guidelines.
Immunohistochemistry. Mice were anesthetized by intraperitoneal injection of ketamine and xylazine and perfused transcardially through the
left ventricle with cold 0.1 M phosphate buffer, pH 7.4, followed by a
phosphate-buffered solution of 4% paraformaldehyde (PFA). Brains
were postfixed with 4% PFA overnight, equilibrated in 15% sucrose overnight, equilibrated in 30% sucrose overnight, frozen, and stored at
⫺80°C until sectioning. Then, 30 m coronal sections in a 1 in 8 series
were made by cryostat and stored at ⫺30°C in cryoprotectant until use.
Every eighth section was processed free floating. Tissue sections were
incubated in 50% formamide in 2⫻ saline/sodium citrate at 65°C for 2 h
for Nampt immunostaining or 10 mM citrate buffer at 65°C for 1 h for all
other antibodies before proceeding with the staining protocol. To remove endogenous peroxidase activity, all sections were incubated with
3% H2O2 for 10 min. Tissue sections were incubated in blocking/permeabilization solution containing 10% normal goat serum, 1% BSA, and
0.3% Triton-X in PBS for 45– 60 min before 24 h of incubation with
primary antibodies in 5% normal goat serum and 0.1% Triton-X in PBS
at 4°C at the following dilutions: activated caspase 3 (1:500, #9661, rabbit;
Cell Signaling Technology), Iba1 (1:500, #019-19741, rabbit; Wako),
Gfap (1:1000, MAB360, mouse; Millipore), Map2 (1:500, M9942, mouse;
Sigma), Nampt (1:1000, ALX-804-717-C100, mouse; Alexis Biochemicals), NeuN (1:500, MAB377, mouse; Millipore), PSD95 (1:500, #2507,
rabbit; Cell Signaling Technology), Synaptophysin (1:1000, S5768,
mouse; Sigma), VGlut1 (1:1000, 135 304, guinea pig; Synaptic Systems).
All antibody specificity was determined by lack of staining after omission
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of primary or secondary antibodies. Alexa Fluor 627 (1:200), Alexa Fluor
488 (1:200), or Cy3 (1:400) conjugated-secondary antibodies (Jackson
ImmunoResearch) diluted in 2% normal goat serum, 1% BSA, and 0.1%
Triton-X in PBS were added for 2 h at room temperature. Detection of
Nampt, Synaptophysin, and Map2 was performed using the TSA-Plus
cyanine 5 kit (PerkinElmer). Nuclei were stained with 4,6-diamidino-2phenylindole (Sigma) for 10 min at room temperature. Highmagnification (20⫻, 0.8 DIC II or 40⫻ oil 1.3 DIC II) microscopic
imaging was performed using a Zeiss Axioimage.Z1 or an Olympus NanoZoomer 2.0-HT. Images were taken in z-stacks of 1 m steps through
the range of tissue section immunoreactivity. Quantification was performed blinded to genotype on 2–3 tissue sections per animal. Verification of colocalization was achieved by performing 3D rendering on stacks
of Z-images with ImageJ.
Golgi-Cox staining and analysis. Mice were decapitated and the brains
were quickly removed from the skull, washed in MilliQ water, and processed immediately for impregnation using the Rapid GolgiStain kit according to manufacturer’s instructions (FD NeuroTechnologies). Brains
were sectioned using a cryostat at ⫺22°C at a thickness of 100 m.
Golgi-impregnated neurons were filled completely such that their soma
and dendrites were clearly visible. Neurons located in CA1’s stratum
pyramidale were traced with ImageJ’s NeuronJ plugin and Sholl analysis
was performed with ImageJ’s Sholl analysis plugin, with spheres centered
on the soma, beginning at a radius of 20 m and increasing in size by 10
m increments.
Western blotting. Protein extracts (15–50 g) were prepared from
acutely isolated mouse hippocampi flash frozen in liquid nitrogen and
stored at ⫺80°C until use, as described previously (Yoshino et al., 2011).
Membranes were incubated with primary antibodies in TBST overnight
at 4°C. Primary antibodies used: activated caspase 3 (1:1000, #9661, rabbit; Cell Signaling Technology), Gfap (1:3000, MAB360, mouse; Millipore), LC3 (1:2000; NB600-1384, rabbit; Novus), Map2 (1:1000, M9942,
mouse; Sigma), Nampt (1:3000; ALX-804-717-C100, mouse; Alexis Biochemicals), Spectrin (1:1000, MAB1622, mouse; Millipore), Synaptophysin (1:1000, S5768, mouse; Sigma), and ␤-tubulin (1:500, sc-9104,
rabbit; Santa Cruz Biotechnology).
Quantitative real-time RT-PCR. Total RNA was isolated from mouse
hippocampi flash frozen in liquid nitrogen and stored at ⫺80°C before
extraction using the RNeasy kit (QIAGEN). RNA was reverse transcribed
into cDNA with the High Capacity cDNA Reverse Transcription kit (Applied Biosystems). Quantitative real-time RT-PCR was conducted with
the TaqMan Fast Universal PCR Master mix and appropriate TaqMan
primers for each gene in the GeneAmp 7500 fast sequence detection
system (Applied Biosystems). Relative expression levels were calculated
for each gene by normalizing to GAPDH levels and then to a control.
Experimental design of behavioral studies. Behavioral tests were conducted on two separate cohorts of CaMKII␣Nampt ⫺ / ⫺ and littermate
control mice. The first cohort of CaMKII␣Nampt ⫺ / ⫺ mice (n ⫽ 16; 7
male, 8 female) and littermate control mice (n ⫽ 15; 7 male, 8 female)
was evaluated on the 1 h locomotor activity test, battery of sensorimotor
measures, Morris water maze (MWM) navigation task, and conditioned
fear, in that order. The second, naive cohort of CaMKII␣Nampt ⫺ / ⫺
mice (n ⫽ 16; 7 male, 9 female) and littermate control mice (n ⫽ 15; 7
male, 8 female) was tested on the elevated plus maze (EPM). Behavioral
tests were conducted by observers unaware of the genotypes of individual
mice.
One hour locomotor activity and sensorimotor battery. Locomotor activity was evaluated using transparent (47.6 ⫻ 25.4 ⫻ 20.6 cm high)
polystyrene enclosures and computerized photobeam instrumentation
as described previously (Wozniak et al., 2004; Dougherty et al., 2013).
General activity variables (total ambulations, vertical rearings, along with
indices of emotionality including time spent, distance traveled and entries made in a 33 ⫻ 11 cm central zone, and distance traveled in a 5.5 cm
contiguous peripheral zone were analyzed. The following day, mice were
evaluated on a battery of sensorimotor tests designed to assess balance
(ledge and platform), strength (inverted screen), coordination (pole and
inclined screens), and initiation of movement (walking initiation), as
described previously (Wozniak et al., 2004; Grady et al., 2006). For the
walking initiation test, a mouse was placed on a surface in the center of a
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21 ⫻ 21 cm square marked with tape and the time the mouse took to
leave the square was recorded. During the balance tests, the time that a
mouse remained on a Plexiglas ledge (0.75 cm wide) or a small circular
wooden platform (3.0 cm in diameter) elevated 30 or 47 cm, respectively,
was recorded. The pole test involved placing a mouse “head up” with its
forepaws on top of a finely textured rod (diameter 8 mm; height 55 cm)
and timing how long it took the mouse to turn and climb down the pole.
If the mouse fell off the pole during a trial, it received a maximum score
of 120 s. The screen tests were conducted by placing a mouse headoriented down in the middle a wire mesh grid measuring 16 squares per
10 cm, elevated 47 cm and angled at 60° or 90°. The time the mouse
required to turn 180° and climb to the top of the apparatus was recorded.
For the inverted screen, a mouse was placed on the screen as described
previously in this section. Once the mouse appeared to have a secure grip,
the screen was inverted 180° and the time the mouse remained on the
screen was recorded. Each test had a maximum time of 60 s, except for the
pole test, which had a maximum time of 120 s. The averaged time of two
trials for each test was used for the analyses.
MWM navigation. Spatial learning and memory were evaluated by the
MWM using a computerized tracking system (ANY-maze; Stoelting) as
described previously (Wozniak et al., 2004; Dougherty et al., 2013) the
day after the completion of the sensorimotor battery. Cued (visible platform, variable location) and place (submerged, hidden platform, constant location) trials were conducted and escape path length, latency, and
swimming speeds were computed. The cued condition involved conducting four trials per day (60 s maximum per trial) for two consecutive
days with the platform being moved to a different location for each trial
using a 30 min intertrial interval (ITI) and with very few distal spatial
cues being present to limit spatial learning. Performance was analyzed
across four blocks of trials (two trials/block). Three days later, place trials
were initiated to assess spatial learning, in which mice were required to
learn the single location of a submerged platform in the presence of
several salient distal spatial cues. During place trials, the mice received 2
blocks of 2 consecutive trials (60 s maximum for a trial; 30 s ITI spent on
platform) with each block being separated by ⬃2 h and each mouse being
released from a different quadrant for each trial. The place trials data
were analyzed over five blocks of trials (four trials/block), in which each
block represented the performance level for each of five consecutive days.
A probe trial (60 s maximum) was administered ⬃1 h after the last place
trial on the fifth day of training with the platform being removed and the
mouse being released from the quadrant opposite to where the platform
had been located. Time spent in the various pool quadrants, including
the target quadrant where the platform had been placed, and crossings
over the exact platform location served as the dependent variables.
Conditioned fear. Conditioned fear was evaluated as described previously (Wozniak et al., 2007; Sato et al., 2012) 54 d after examining spatial
learning and memory in the MWM. Briefly, mice were trained and tested
in two Plexiglas conditioning chambers (26 cm ⫻ 18 cm, and 18 cm high;
Med-Associates), with each chamber containing distinct and different
visual, odor, and tactile cues. Each mouse was placed into the conditioning chamber for a 5 min trial and freezing behavior was quantified during
a 2 min baseline period. Beginning at 3 min and at 60 s intervals thereafter, the mice were exposed to 3 T/S pairings, with each pairing including
a 20 s presentation of an 80 dB tone (conditioned stimulus; CS) consisting of broadband white noise followed by a 1.0 mA continuous foot
shock (unconditioned stimulus; US) presented during the last second of
the tone. Broadband white noise was used instead of a frequency-specific
tone in an effort to avoid possible auditory deficits that might occur with
age. The mice were placed back into the conditioning chamber the following day and freezing behavior was quantified over an 8 min period to
evaluate contextual fear conditioning. Twenty-four hours later, the mice
were placed into a different chamber containing different cues. Freezing
behavior was quantified during a 2 min “altered context” baseline and
over the subsequent 8 min, during which time the auditory cue (tone;
CS) was presented. Freezing was quantified using FreezeFrame image
analysis software (Actimetrics), which allowed for simultaneous visualization of behavior while adjusting a “freezing threshold,” which categorized behavior as freezing or not freezing during 0.75 s intervals. Freezing
was defined as no movement except for that associated with normal
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respiration and the data are presented as percentage of time spent freezing. Shock sensitivity was evaluated after completion of the conditioned
fear testing according to our previously described procedures (Khuchua
et al., 2003).
EPM. Anxiety-like behaviors were assessed using the EPM according
to our previously described procedures (Schaefer et al., 2000; Dougherty
et al., 2013). Our apparatus consisted of two opposing open arms and two
opposing enclosed arms (36 ⫻ 6.1 ⫻ 15 cm) that extended from a central
platform (5.5 ⫻ 5.5 cm) constructed of black Plexiglas. The maze was
equipped with pairs of photocells configured in a 16 (x-axis) ⫻ 16 ( yaxis) matrix, the output of which was recorded by a computer and interface assembly (Kinder Scientific). A system software program
(MotorMonitor; Kinder Scientific) enabled the beam-break data to be
recorded and analyzed to quantify time spent, distance traveled, and
entries made into the open and closed arms and center area. To adjust for
differences in general activity, the percentage of distance traveled, time
spent, and entries made into the open arms out of the totals (open arms
⫹ closed arms) for each variable were also computed. Test sessions were
conducted in a dimly lit room where light was provided by two 13-watt
blacklight bulbs (EcoBulbs; Feit) and each session began by placing a
mouse in the center of the maze and allowing it to freely explore the
apparatus. Each test session lasted 5 min and the mice were tested over 3
consecutive days.
LTP. LTP was evaluated using previously described methods (Bukalo
and Dityatev, 2006; Tokuda et al., 2010). Briefly, hippocampal slices were
prepared from 60-d-old mice. Mice were anesthetized with isoflurane
and decapitated. Hippocampi were rapidly dissected and placed in artificial CSF (ACSF) containing the following (in mM): 124 NaCl, 5 KCl, 2
MgSO4, 2 CaCl2, 1.25 NaH2PO4, 22 NaHCO3, 10 glucose, gassed with
95% O2–5% CO2 at 4 – 6°C, and sectioned transversely into 400 – 450 m
slices using a rotary slicer. Acutely prepared slices were placed in an
incubation chamber containing gassed ACSF for at least 1 h at 30°C.
Slices were then transferred individually to a submersion-recording
chamber. Experiments were performed at 30°C with continuous perfusion of ACSF at 2 ml/min. Extracellular recordings were obtained from
the CA1 apical dendritic region (stratum radiatum) for analysis of field
EPSPs (fEPSPs) and from the pyramidal cell layer (stratum pyramidale)
for analysis of fiber volleys and population spikes using 2 M NaCl glass
electrodes (5–10 M⍀). Responses were elicited with 0.1 ms constant
current pulses through a bipolar electrode in the Schaffer collateral pathway. fEPSPs were measured by the maximal slope of their rising phase
and fiber volleys and population spikes were measured as maximal peakto-trough amplitudes. A baseline (control) input-output (IO) curve was
obtained to determine stimulus intensities for subsequent analyses. IO
curves were generated using stimuli of six different intensities to allow
determination of half-maximal responses. The smallest stimulus was set
to evoke a response less than half maximal and the largest stimulus was
designed to evoke a fully saturated response. During an experiment,
evoked fEPSPs were monitored by applying single stimuli to the Schaffer
collateral pathway every 60 s at an intensity sufficient to elicit half maximal responses. After establishing a stable baseline, LTP was induced by
applying a single 100 Hz ⫻ 1 s high-frequency stimulus (HFS) using a
stimulus of the same intensity. IO curves were repeated 60 min after
delivery of low-frequency stimulation (LFS; 1 Hz ⫻ 900 pulses) and then
60 min after delivery of HFS (100 Hz ⫻ 100 pulses ⫻ 1 s) to determine the
magnitude of LTP based on changes in half maximal responses.
For investigation of paired-pulse plasticity, dual stimuli of identical
intensity were delivered at an interval of 21 ms. The stimulus intensity
was initially set below threshold for evoking responses and increased in a
stepwise fashion every 10 s until six pairs of stimuli were administered.
Methods for analyzing paired-pulse changes in somatic excitability based
on IO curves are detailed in the Figure 5C legend.
Statistical analyses. All numerical data are presented as mean ⫾ SEM.
Statistical significance between control and experimental samples was
determined by unpaired Student’s t tests with p ⬍ 0.05 representing a
statistically significant difference. For the behavioral data, ANOVA models were used. Repeated-measures ANOVA (rmANOVA) models containing two between-subjects variables (genotype and sex) and one
within-subject (repeated-measures) variable (e.g., blocks of trials) were
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Bonferroni correction when appropriate, although planned comparisons were also
conducted.

Results

CaMKII␣Nampt ⴚ / ⴚ mice are overtly
normal but show altered CA1
morphology at 2–3 months of age
At 2–3 months of age, CaMKII␣Nampt ⫺ / ⫺
mice looked overtly normal relative to littermate control mice (Fig. 1A). The body
weights of female CaMKII␣Nampt ⫺ / ⫺
mice were indistinguishable from control
mice (Student’s t test, p ⫽ 0.38, n ⫽ 22–26),
whereas the body weights of male
CaMKII␣Nampt ⫺ / ⫺ mice were slightly,
but significantly, lower than control mice
(Fig. 1B; Student’s t test, p ⫽ 0.0001, n ⫽
20 –26). Because the CaMKII␣Cre driver
mediates recombination in excitatory neurons of the forebrain, we examined the
morphology of CaMKII␣Nampt ⫺ / ⫺ and
control brains by gross inspection and H&E
staining (Fig. 1C–E). CaMKII␣Nampt ⫺ / ⫺
brains looked slightly smaller than control
brains at 2–3 months of age (Fig. 1C). Consistent with this observation, we noticed a
visible decrease in the thickness of the CA1
stratum pyramidale and an increase in total
cells present in the stratum radiatum and
stratum oriens. Quantitatively, the total
brain weight of CaMKII␣Nampt ⫺ / ⫺ mice
was 9% smaller than that of control mice
(Fig. 1F; Student’s t test, p ⫽ 0.03, n ⫽ 5).
Similarly, the total weight of each hippocampi in CaMKII␣Nampt ⫺ / ⫺ mice was
16% smaller than that of control mice (Fig.
1G; Student’s t test, p ⫽ 0.01, n ⫽ 5). Using
DAPI staining to quantify the cell loss, we
found that CaMKII␣Nampt ⫺ / ⫺ mice had
44% fewer DAPI ⫹ cells in (Student’s t test,
p ⫽ 0.00001, n ⫽ 5) and a 54% decrease in
the width of CA1’s stratum pyramidale (Fig.
1H,I; Student’s t test, p ⫽ 0.00001, n ⫽ 5).
To validate the recombination pattern
produced by the CaMKII␣Cre driver, we
examined Nampt protein expression by
⫺/⫺
in 2- to 3-monthFigure 1. CaMKII␣Nampt
mice are overtly normal but show altered CA1 morphology at 2–3 months of age. A, Repre- immunohistochemistry
⫺/⫺
and control
sentative images of CaMKII␣Nampt ⫺ / ⫺ and control mice. B, Body weights of CaMKII␣Nampt ⫺ / ⫺ mice (n ⫽ 22–26) and old CaMKII␣Nampt
control mice (n ⫽ 20 –26). C, Representative images of the brains of CaMKII␣Nampt ⫺ / ⫺ and control mice. D, H&E staining of mice. In both genotypes, Nampt was excoronal brain sections. Scale bars, 500 m. E, Magnification of the CA1 hippocampal subregion from D. Scale bars, 50 m. F, Brain pressed in neurons, but not astrocytes, of
weights of CaMKII␣Nampt ⫺ / ⫺ and control mice (n ⫽ 5). G, Hippocampal weights of CaMKII␣Nampt ⫺ / ⫺ and control mice the hippocampus, as shown previously
(n ⫽ 5). H, I, Quantification of immunohistochemistry in the CA1 stratum pyramidale (n ⫽ 5). H, The number of DAPI ⫹ cells (Zhang et al., 2010; Wang et al., 2011b; Fig.
present per length of the CA1 stratum pyramidale. I, Width of the CA1 stratum pyramidale, calculated as CA1 area per CA1 length. 2A–C). However, CaMKII␣Nampt ⫺ / ⫺
Data are presented as mean ⫾ SEM. *p ⬍ 0.05; **p ⬍ 0.01; ***p ⬍ 0.001.
mice exhibited a striking loss of Nampt immunoreactivity in neurons of the CA1 subregion of the hippocampus (Fig. 2A) and, to
typically used to analyze the MWM, conditioned fear, and EPM data. The
Huynh-Feldt adjustment of ␣ levels was used for all within-subject
a lesser extent, in neurons of the DG and CA3 subregions (Fig.
effects containing more than two levels to protect against violations of
2B,C). Quantification of these differences in CA1 revealed that
sphericity/compound symmetry assumptions underlying rmANOVA
CaMKII␣Nampt ⫺ / ⫺ mice had 38% fewer cells expressing
models. Typically, one-way ANOVA models were used to analyze difNampt (Fig. 2D; Student’s t test, p ⫽ 0.0007, n ⫽ 5). Immunoferences between groups for measures in the 1 h locomotor activity and
blotting whole hippocampal extracts showed a significant 30%
the sensorimotor battery tests. Pairwise comparisons were conducted
decrease in Nampt protein levels in CaMKII␣Nampt ⫺ / ⫺ relative
after relevant, significant overall ANOVA effects and were subjected to
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to control mice (Fig. 2E; 0.54 ⫾ 0.04 in
CaMKII␣Nampt ⫺ / ⫺ mice vs 0.77 ⫾ 0.04
in control mice at 6 –7 months of age; Student’s t test, p ⫽ 0.006, Nampt intensity
normalized by ␤-tubulin, n ⫽ 9). This
30% reduction in Nampt protein expression is consistent with the CA1-specific
nature of the deletion. To further confirm
the reduction in Nampt, we measured
NAD ⫹ levels in hippocampal extracts of
2- to 3-month-old CaMKII␣Nampt ⫺ / ⫺
and control mice (Fig. 2F ). Hippocampal
NAD ⫹ levels in CaMKII␣Nampt ⫺ / ⫺
mice were reduced 26% relative to control
mice (Student’s t test, p ⫽ 0.007, n ⫽ 12–
14), whereas ATP levels between the two
genotypes were indistinguishable (Fig.
2G; Student’s t test, p ⫽ 0.34, n ⫽ 12).
CaMKII␣Nampt ⫺ / ⫺ mice also exhibited
identical mortality rates relative to control
mice through 14 months of age (the latest
age checked, data not shown).
CaMKII␣Nampt ⴚ / ⴚ mice exhibit
astrogliosis and microgliosis in the
forebrain
As in the hippocampus, Nampt immunoreactivity appeared to be reduced in
the cortex of CaMKII␣Nampt ⫺ / ⫺ mice
relative to control mice (Fig. 3A). In
control mice, cortical layer I was easily
distinguishable by its low cell density
(Fig. 3 A, B). In contrast, the cortical layers of CaMKII␣Nampt ⫺ / ⫺ mice were
indistinguishable by cell density. Although loss of NeuN ⫹ neurons was
mainly prevalent in CA1, all three hippocampal subregions and the cortex
also demonstrated a dramatic increase
in Gfap ⫹ immunoreactivity (Fig. 3A),
⫺/⫺
mice show prominent deletion of Nampt and cell loss in CA1 at 2–3 months of age. A–C,
suggesting astrogliosis. Because of this Figure 2. CaMKII␣Nampt
Representative
images
of
Immunofluorescence
for DAPI (blue), Nampt (red), and NeuN (green) in coronal sections (n ⫽ 5).
massive astrogliosis, we investigated
mice, NeuN ⫹ neurons express Nampt. This expression is greatly reduced in the DG, CA3, and
whether the populations of other cell Scale bars, 20 M. In control
CA1 of CaMKII␣Nampt ⫺ / ⫺ mice. D, Quantification of immunohistochemistry in the CA1 stratum pyramidale (n ⫽ 5). The
types were affected. Immunohisto- percentage of DAPI ⫹ cells that express Nampt. E, Representative immunoblots of hippocampal extracts of
chemistry for Iba1 also revealed exten- CaMKII␣Nampt ⫺ / ⫺ and control mice at 6 –7 months of age. F, HPLC analysis in hippocampal extracts of
sive microglial activation in all CaMKII␣Nampt ⫺ / ⫺ mice (n ⫽ 14) and control mice (n ⫽ 12) shows significantly reduced NAD ⫹ levels. G, HPLC analysis
hippocampal subregions and the cortex, in hippocampal extracts of CaMKII␣Nampt ⫺ / ⫺ and control mice shows similar ATP levels (n ⫽ 12). Data are presented as
indicative of an inflammatory response mean ⫾ SEM. *p ⬍ 0.05; **p ⬍ 0.01; ***p ⬍ 0.001.
(Fig. 3B). Quantitative PCR analysis reage. Consistent with this notion, immunoblotting for activealed a 6-fold increase in Gfap (Student’s t test, p ⫽
vated caspase 3 failed to detect any differences between 2- and
0.0000004, n ⫽ 11–14) and a 2.3-fold increase in Iba1 (Stu3-month-old CaMKII␣Nampt ⫺ / ⫺ and control mice (Fig. 3E).
dent’s t test, p ⫽ 0.002, n ⫽ 11–14) mRNA expression in the
⫺/⫺
To assess autophagy, we determined the formation of LC3B-II,
hippocampi of CaMKII␣Nampt
mice relative to control
an autophagosome-membrane-associated form of LC3B that
mice (Fig. 3C).
correlates with the induction of autophagy. However, immunoDue to the substantial neuronal loss in the CA1 subregion of
blotting for LC3B failed to detect any differences between
2- to 3-month-old CaMKII␣Nampt ⫺ / ⫺ mice (Figs. 1E, 2A), we
CaMKII␣Nampt ⫺ / ⫺ mice and control mice in the levels of the
investigated whether the Nampt-deficient neurons were dying.
LC3B-I and LC3B-II species (Fig. 3E). To assess excitotoxicity, we
Immunohistochemistry for TUNEL (Fig. 3B) or activated
checked spectrin breakdown products: the 280 kDa spectrin procaspase 3 (Fig. 3D), markers of cell death, revealed very few
positive cells in either genotype, indicating that neither apotein can be cleaved to unique 150 and 145 kDa fragments by
calpain (Bevers and Neumar, 2008). The 145 kDa product of
ptosis nor necrosis was occurring at substantial levels at this
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CaMKII␣Nampt ⴚ / ⴚ mice show
specific CA1 and cortical dendritic loss
and swelling but intact expression of
synaptic markers at 2–3 months of age
Calpain activation is known to result in loss
of Map2 immunoreactivity upon injury
(Matesic and Lin, 1994; Pettigrew et al.,
1996; Minger et al., 1998). Intriguingly, we
found that, in CaMKII␣Nampt ⫺ / ⫺ mice,
CA1 stratum oriens exhibited a complete
loss of Map2 staining and the stratum radiatum highlighted a sparse layer of swollen
dendrites (Fig. 4A). In contrast, control
mice exhibited long, string-like apical and
basal Map2 ⫹ dendrites in the stratum radiatum and stratum oriens, respectively (Fig.
4A), as reported previously (Kitagawa et
al., 1989; Kwei et al., 1993; Matesic and
Lin, 1994; Folkerts et al., 1998; Jalava et al.,
2007). No Map2 immunostaining was
found in DAPI ⫹ nuclei or in the myelin
tracts. Loss of Map2 ⫹ dendrites upon injury is thought to occur both before and
during spectrin degradation by calpain
(Matesic and Lin, 1994; Pettigrew et al.,
1996; Minger et al., 1998). Therefore, to
determine whether the observed changes
were specific to Map2, we assessed the localization of this cytoskeletal protein.
Spectrin immunoreactivity was indistinguishable between CaMKII␣Nampt ⫺ / ⫺
and control mice, indicating that, whereas
calpain-mediated cleavage of spectrin had
increased, its degradation had not (data
not shown).
To quantify these changes in dendritic
arborization, we performed Golgi-Cox
impregnation and Sholl analysis on impregnated cells in CA1’s stratum pyramidale. CaMKII␣Nampt ⫺ / ⫺ mice showed a
reduction in dendritic arborization, with
a significant decrease in intersections at
multiple distances from the soma (Fig.
4B,C; Student’s t tests, p ⫽ 0.01– 0.002, n ⫽
4 –5 mice, 10 neurons per mouse). This
analysis also revealed a drastic reduction in
Figure 3. CaMKII␣Nampt ⫺ / ⫺ mice show extensive CA1 and cortical astrogliosis and microgliosis without obvious cell death the number of impregnated neurons, sugat 2–3 months of age. A, B, D, Representative images of Immunofluorescence (n ⫽ 5–9) taken in coronal sections. Scale bars, 50
gesting a reduced neuronal population
M. A, Immunofluorescence for DAPI (blue), Nampt (red), and Gfap (green). B, Immunofluorescence for DAPI (blue), Iba1 (red),
(control mice: 189 ⫾ 8 cells/mm 2;
and TUNEL (green). C, Quantitative PCR analysis with hippocampal RNA samples of CaMKII␣Nampt ⫺ / ⫺ mice (n ⫽ 11) and
CaMKII␣Nampt ⫺ / ⫺ mice: 83 ⫾ 17 cells/
control mice (n ⫽ 14) shows a 6-fold increase in Gfap and a 2.3-fold increase in Iba1 mRNA expression. D, Immunofluorescence for
mm 2; Student’s t test, p ⫽ 0.0008, n ⫽ 4 –5).
DAPI (blue) and activated caspase 3 (red) shows no obvious difference in cell death between CaMKII␣Nampt ⫺ / ⫺ mice and
controls. Arrow highlights a rare activated caspase 3 ⫹ cell. E, Representative images of immunoblots in CaMKII␣Nampt ⫺ / ⫺ Despite these remarkable histological
mice (n ⫽ 4) and control mice (n ⫽ 5) shows a lack of overt cell death (activated caspase 3: 17, 19 kDa; LC3: 17, 19 kDa) and a slight changes, mRNA expression of markers of
increase in the 145/150 kDa spectrin (280, 145, 150, 100 kDa) breakdown product and the presence of astrogliosis (Gfap: 55 kDa). excitatory neurons (NR1, NR2A, NR2B),
Immunoblots were normalized by Gapdh (36 kDa). Data are presented as mean ⫾ SEM. *p ⬍ 0.05; **p ⬍ 0.01; ***p ⬍ 0.001. synapses (Dlg4), GABAergic signaling
(GabaR␥1, GabaR␣2), or synaptic plasticity
(Bdnf) were all similar between 2- and
spectrin appeared to increase in CaMKII␣Nampt ⫺ / ⫺ mice rela3-month-old CaMKII␣Nampt ⫺ / ⫺ and control mice (Fig. 4D).
tive to control mice, implying some calpain activation due to
Only two immediate early genes (Arc, Egr1) showed significant reexcitotoxicity (Fig. 3E; control mice: 0.73 ⫾ 0.04;
duction in their mRNA expression in CaMKII␣Nampt ⫺ / ⫺ mice
CaMKII␣Nampt ⫺ / ⫺ mice: 0.93 ⫾ 0.06; Student’s t test, p ⫽
relative to control mice (Fig. 4D; Student’s t tests, Arc: p ⫽ 0.001, n ⫽
0.012, n ⫽ 9). The increase in Gfap gene expression was also seen
11–14; Egr1: p ⫽ 0.002, n ⫽ 11–14).
at the protein level (Fig. 3E).
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To determine whether this dendritic
abnormality extended to the synapses, we
performed immunohistochemistry for
synaptophysin, a marker for presynaptic
terminals; vesicular glutamate transporter
1 (VGlut1), a marker of glutamatergic
synaptic vesicles (Santos et al., 2009); and
postsynaptic density protein 95 (PSD95),
a marker of excitatory postsynaptic densities (Aarts and Tymianski, 2004) in the
stratum radiatum. Surprisingly, the intensity of synaptophysin was overtly normal
in CaMKII␣Nampt ⫺ / ⫺ mice (Fig. 4E),
confirming no major defects in synaptic
protein expression. Consistent with this,
and supporting the notion of a CA1specific effect, immunoblotting for Map2
and synaptophysin in hippocampal extracts failed to detect any differences between CaMKII␣Nampt ⫺ / ⫺ and control
mice (Fig. 4F ). VGlut1 expression in the
hippocampus was significantly higher in
CaMKII␣Nampt ⫺ / ⫺ mice both when assessed by mean intensity (Fig. 4G, control
mice: mean intentisy 111 ⫾ 7 arbitrary
units [AU], n ⫽ 6; CaMKII␣Nampt ⫺ / ⫺
mice: mean intensity 136 ⫾ 6 AU, n ⫽ 7;
Student’s t test, p ⫽ 0.02) and by the
percentage of CA1 area covered by the
thresholded VGlut1 immunoreactive
signal (control mice: 16 ⫾ 9% of CA1
area, n ⫽ 6; CaMKII␣Nampt ⫺ / ⫺ mice:
49 ⫾ 9% of CA1 area, n ⫽ 7; Student’s t
test, p ⫽ 0.02). In contrast, PSD95 expression in the hippocampus trended to
decrease in CaMKII␣Nampt ⫺ / ⫺ mice
(mean intensity 85 ⫾ 4 AU, n ⫽ 7) relative
to control mice (mean intensity 95 ⫾ 4 AU,
Student’s t test, p ⫽ 0.12, n ⫽ 6).
Although these normal expression patterns do not confirm correct localization
of these proteins, they suggest that
CaMKII␣Nampt ⫺ / ⫺ mice have intact
synaptic components. In addition, because VGlut1 expression levels determine
the amount of glutamate stored and released per vesicle (Wojcik et al., 2004; Wilson et al., 2005), the increase in VGlut1
expression and decrease in PSD95 expression could indicate an imbalance between
presynaptic glutamate release and postsynaptic densities.
CaMKII␣Nampt ⴚ / ⴚ mice exhibit
altered hippocampal physiology at 2–3
months of age
With such overt effects on dendritic morphology, we suspected that CA1 synaptic
function might be altered. To test this possibility, we stimulated the Schaffer collateral inputs in the CA1 region of
hippocampal slices from P60 mice.
Stimulation of the Schaffer collateral in-
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Figure 4. CaMKII␣Nampt ⫺ / ⫺ mice show altered dendritic integrity in the absence of overt synapse loss in CA1 at 2–3 months
of age. A, Representative images of Immunofluorescence for DAPI (blue) and Map2 (green) in control and CaMKII␣Nampt ⫺ / ⫺
coronal sections (n ⫽ 5–9). Scale bars, 50 m. There is a reduction of the number and change in the orientation of CA1 dendrites
of CaMKII␣Nampt ⫺ / ⫺ mice relative to control mice. B, C, Golgi-Cox impregnation of CA1 pyramidal neurons. B, Sholl analysis of
impregnated CaMKII␣Nampt ⫺ / ⫺ showed a reduction in dendritic arborization. C, Representative traces of Golgi-Cox impregnation in control and CaMKII␣Nampt ⫺ / ⫺ coronal sections (n ⫽ 4 –5). Scale bars, 50 m. D, Quantitative PCR analysis in hippocampal RNA samples of CaMKII␣Nampt ⫺ / ⫺ mice (n ⫽ 5–11) and control (n ⫽ 5–14) mice shows no change in markers of excitatory
neurons (NR1, NR2A, NR2B), synapses (Dlg4 ), interneurons (GabaR␥1, GabaR␣2), or synaptic plasticity (Bdnf ), but a reduction in
immediate early genes (Arc, Egr1). E, Immunofluorescence for DAPI (blue) and Synaptophysin (green) shows no obvious difference
in Synaptophysin intensity between CaMKII␣Nampt ⫺ / ⫺ and control mice. Scale bars, 50 m. F, Representative images of
immunoblots in CaMKII␣Nampt ⫺ / ⫺ mice (n ⫽ 4) and control mice (n ⫽ 5) show similar levels of Map2 and Synaptophysin. C,
Control; N, CaMKII␣Nampt ⫺ / ⫺. G, Immunofluorescence for DAPI (blue) and VGlut1 (green) shows an increase in VGlut1 intensity
in CaMKII␣Nampt ⫺ / ⫺ mice. Scale bars, 20 m. Data are presented as mean ⫾ SEM. *p ⬍ 0.05; **p ⬍ 0.01; ***p ⬍ 0.001.
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Figure 5. CaMKII␣Nampt ⫺ / ⫺ mice show altered Schaffer-collateral pathway physiology at 2–3 months of age. A,
Representative fEPSPs obtained from control mice show a small presynaptic volley (arrow) relative to the population spike
(n ⫽ 5). Calibration: 1 mV, 5 ms. B, Representative fEPSPs obtained from CaMKII␣Nampt ⫺ / ⫺ mice show a large presynaptic volley (arrow) relative to the population spike (n ⫽ 5). C, Assessment of PS amplitude (height) upon paired-pulse
stimulation. Because both dendritic fEPSPs and PS height are altered by paired-pulse stimulation, we used an analysis of IO
curves to calculate the size of fEPSP required to generate a half-maximal PS after the first (top) and second (bottom) paired
stimuli. The IO curves of the first stimuli in the top are repeated in the bottom for clarity. The left graphs show typical IO
curves for dendritic fEPSPs (circles) and PSs (triangles) in a slice from a control mouse. The stimulus intensity needed to
evoke a half-maximal PS by the first stimulation (top) was determined by the intersection of the horizontal 50% maximal
line with a line connecting the two points straddling the half maximal value (shown by the green solid line between two PS
points in black triangles in bottom). We then used this value to calculate the size of dendritic fEPSP required to generate a
PS of this magnitude, shown as the intersection of the upward red arrow and the solid blue line connecting two points
(black circles), on the initial fEPSP IO curve. We next calculated the stimulus intensity required for the second (paired)
stimulus to induce an equivalent fEPS, shown as a horizontal red arrow intersecting the dotted blue line, from the second
pulse fEPSP curve (white circles). At this stimulus intensity, we could then determine the PS amplitude generated by the
second stimulation, shown as a downward red arrow intersecting the dotted green line on the second PS curve (white
triangle). This analysis shows that the PS generated by a second stimulation at an equivalent fEPSP size is much smaller
than the PS produced by the initial stimulus, indicating the presence of significant paired-pulse depression. The right
graphs show a similar analysis of IO curves in a slice from a CaMKII␣Nampt ⫺ / ⫺ mouse. The marked paired-pulse
depression of PS amplitude observed in the control slice is not seen in the CaMKII␣Nampt ⫺ / ⫺ mouse, despite clear
paired-pulse potentiation of dendritic fEPSPs, manifest as a leftward shift in the fEPSP IO curves (black vs white circles). The
dashed arrow in the lower left graph depicts the 50% maximal fEPSP; this stimulus intensity was used to monitor fEPSPs in LTP studies.

puts reliably evoked fEPSPs and population spikes in control and
CaMKII␣Nampt ⫺ / ⫺ mice. Consistent with the changes we observed in dendritic morphology, however, we found that fEPSPs
and population spikes in slices from CaMKII␣Nampt ⫺ / ⫺ mice
consistently required a large presynaptic fiber volley compared
with controls (Fig. 5 A, B). We quantified this effect by analyzing
the ratio of presynaptic fiber volley amplitude required to evoke a
maximal population spike. Although the difference did not reach
statistical significance, the ratio of presynaptic volley to maximal
population spike was only 4.7 ⫾ 2.5% in control mice (Fig. 5A),
consistent with prior work (Bukalo and Dityatev, 2006), whereas
the ratio was 110.9 ⫾ 85.1% in CaMKII␣Nampt ⫺ / ⫺ mice (Fig. 5B).
Furthermore, even with maximal stimuli, we consistently observed larger fiber volleys and smaller maximal population spikes
in CaMKII␣Nampt ⫺ / ⫺ mice compared with controls (maximal
fiber volleys: control mice: 0.12 ⫾ 0.05 mV; CaMKII␣Nampt ⫺ / ⫺

mice: 0.78 ⫾ 0.27 mV; Student’s t test, p ⫽
0.046, n ⫽ 5; maximal population spikes:
control mice: 3.67 ⫾ 0.70 mV;
CaMKII␣Nampt ⫺ / ⫺ mice: 1.90 ⫾ 0.44
mV; Student’s t test, p ⫽ 0.07, n ⫽ 5).
These findings indicate that, despite having
intact
synaptic
responses,
CaMKII␣Nampt ⫺ / ⫺ mice have altered
inputs into CA1 and diminished somatic excitability in response to synaptic activation.
Presynaptic alterations in the Schaffer
collateral pathway can affect paired-pulse
plasticity (Capogna, 1998; Nicoll and
Malenka, 1999). Therefore, we assessed
fEPSPs and population spikes (PSs) of
control and CaMKII␣Nampt ⫺ / ⫺ mice
upon paired-pulse stimulation delivered at an interval of 21 ms. To quantify
changes in paired-pulse plasticity, we
first determined the amplitude of a
fEPSP that generated a 50% maximal PS
evoked by the initial stimulation (Fig.
5C, top) and then found the size of the
second PS generated by the equivalent
fEPSP evoked by the second (paired)
stimulation (Fig. 5C, bottom). As is typically seen (Capogna, 1998), we observed paired-pulse depression of PSs in
control slices after adjusting for the size
of dendritic fEPSPs (second PS ⫽
40.3 ⫾ 18.7% of initial PS amplitude,
n ⫽ 6). In contrast, slices from
CaMKII␣Nampt ⫺ / ⫺ mice did not exhibit similar paired-pulse depression (second PS ⫽ 116.6 ⫾ 11.5% of initial PS
amplitude; Student’s t test, p ⫽ 0.004, n ⫽
7). A typical pattern of paired-pulse PS depression in a slice from a control mouse
highlights differences between control (Fig.
5C, bottom left) and CaMKII␣Nampt ⫺ / ⫺
mice (Fig. 5C, bottom right). These results
again support the conclusion that
CaMKII␣Nampt ⫺ / ⫺ mice have altered somatic excitability in response to synaptic inputs.

CaMKII␣Nampt ⴚ / ⴚ mice exhibit hyperactivity and mild
sensorimotor deficits
Considering the histological abnormalities observed in 2- to
3-month-old CaMKII␣Nampt ⫺ / ⫺ mice, we conducted several
behavioral analyses to evaluate the possibility that disturbances in
hippocampal function could lead to impaired performance on
certain behavioral tests. We first conducted a 1 h locomotor
activity test and a battery of sensorimotor measures as general
assessments of health and to determine whether certain nonassociative behavioral disturbances were likely to affect learning and memory performance. In the 1 h locomotor activity
test, CaMKII␣Nampt ⫺ / ⫺ mice exhibited a 2.8- to 3.8-fold increase in ambulations (whole-body movements) over control
mice throughout the entire test session (Fig. 6 A, B; rmANOVA,
genotype effect: F(1,27) ⫽ 33.99, p ⬍ 0.00005). Significant differ-

5808 • J. Neurosci., April 23, 2014 • 34(17):5800 –5815

Stein et al. • Forebrain Nampt Is Required for Cognitive Function

ences were also observed for each time
block during the test session (pairwise
comparisons, p ⬍ 0.0003), but not for
main or interaction effects involving sex.
Control mice showed habituation over
the test period, exhibited by a significant
57% decrease (p ⫽ 0.014) in ambulations
between blocks 1 and 6. In contrast,
CaMKII␣Nampt ⫺ / ⫺ mice showed only a
22% decrease in ambulations (p ⫽ 0.054).
In addition, CaMKII␣Nampt ⫺ / ⫺ mice
exhibited a 1.4- to 2.8-fold increase in
exploratory behavior (instances of vertical
rearing) relative to control mice
(rmANOVA, genotype effect: F(1,27) ⫽
21.70, p ⫽ 0.0001), in both a sex- and timedependent manner (genotype ⫻ time:
F(5,135) ⫽ 2.40, p ⫽ 0.05, genotype ⫻ sex:
F(1,27) ⫽ 5.99, p ⫽ 0.021, and genotype ⫻
sex ⫻ time: F(5,135) ⫽ 3.07, p ⫽ 0.017). Specifically, male CaMKII␣Nampt ⫺ / ⫺ mice
reared significantly more often than male
control mice (F(1,27) ⫽ 23.06, p ⫽ 0.0001),
whereas no differences were observed between the groups of female mice (Fig. 6C).
As with their ambulations, control mice
showed significant habituation of instances
of vertical rearing from block 1 to block 6
(53% decrease; F(1,27) ⫽ 25.90, p ⬍
0.00005). Conversely, CaMKII␣Nampt ⫺ / ⫺
mice only showed a nonsignificant 9%
decrease in rearing, suggesting that habituation did not occur. The lack of habituation during activity testing also suggests
possible deficits in novelty acquisition
or other basic learning and memory
capabilities.
To assess possible alterations in emotionality, we compared the activity and
exploration levels in the center versus the
periphery of the 1 h locomotor activity test
arena. Interestingly, CaMKII␣Nampt ⫺ / ⫺
mice made significantly more entries into
⫺/⫺
mice exhibit hyperactivity in the absence of major sensorimotor deficits at 2–3 months of age.
the center of the test arena (1.8-fold; Figure 6. CaMKII␣Nampt
⫺/⫺
A–E,
Evaluation
of
CaMKII
␣
Nampt
mice (n ⫽ 15) and control mice (n ⫽ 16) on the 1 h locomotor test. CaMKII␣Nampt ⫺ / ⫺
F(1,27) ⫽ 7.08, p ⫽ 0.013) and traveled a
significantly greater distance in the center mice showed a much higher average number of ambulations (A) and instances of vertical rearing (B) in each of the six 10 min blocks
of the testing period than did control mice. C, Differences between genotypes in levels of vertical rearing are more pronounced in
(1.9-fold; F(1,27) ⫽ 6.00, p ⫽ 0.021) than male CaMKII␣Nampt ⫺ / ⫺ mice than female CaMKII␣Nampt ⫺ / ⫺ mice. D–H, CaMKII␣Nampt ⫺ / ⫺ mice showed a higher
control mice, suggesting a possible de- number of entries into the center of the test arena (D) and average distance traveled in both the center (E) and the periphery of the
crease in anxiety-like behaviors (Fig. 6D,E). test arena (G) than control mice. The percentage of time spent in the center was similar between genotypes (F ), whereas the
However, because CaMKII␣Nampt ⫺ / ⫺ percentage of distance spent in the periphery was higher in CaMKII␣Nampt ⫺ / ⫺ mice (H ). I–K, Evaluation of
and control mice did not differ in CaMKII␣Nampt ⫺ / ⫺ mice (n ⫽ 15) and control mice (n ⫽ 16) on a battery of sensorimotor tests. CaMKII␣Nampt ⫺ / ⫺ mice
terms of the percentage of time spent in showed increased time to initiate walking (movement) out of a square (I ), decreased time to balance on a ledge (J ), and increased
the center (Fig. 6F ) and because time to climb down a pole (K ). Asterisks represent significance generated from unpaired Student’s t tests. ^ and ^^ represent
CaMKII␣Nampt ⫺ / ⫺ mice traveled a significance generated from rmANOVAs. Data are presented as mean ⫾ SEM. *p ⬍ 0.05; **p ⬍ 0.01; ***p ⬍ 0.001.
significantly greater distance (Figure
pared with control mice. Specifically, CaMKII␣Nampt ⫺ / ⫺ mice
6G; F(1,27) ⫽ 29.31, p ⬍ 0.00005) and percentage of distance (Fig.
were not impaired on the platform, the 90° inclined screen, or the
6H ) in the peripheral zone of the arena, we cannot exclude the
inverted screen tests (data not shown). However, they took sigpossibility that differences observed in the “center” variables are pri⫺/⫺
nificantly longer to move out of a small circumscribed area
marily due to the hyperactivity of the CaMKII␣Nampt
mice
(square) during the walking initiation test (2.3-fold; F(1,27) ⫽
rather than an alteration in emotionality. In these “emotionality”
4.68, p ⫽ 0.040), remained on an elevated ledge for a signifivariables, we did not find any significant effects involving sex.
cantly less time (40%; F(1,27) ⫽ 30.14, p ⬍ 0.00005), and took
In the sensorimotor battery, CaMKII␣Nampt ⫺ / ⫺ mice exsignificantly longer to climb down a pole (2.4-fold; F(1,27) ⫽
hibited performance deficits on three of seven of the tests com-
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tially showed equivalent performance levels with regard to escape path length (Fig.
7A). However, control mice rapidly improved their performance in the subsequent three blocks of trials such that their
performance became far superior to that
of CaMKII␣Nampt ⫺ / ⫺ mice during the
rest of training (rmANOVA, genotype effect: F(1,27) ⫽ 17.18, p ⫽ 0.0003; genotype ⫻ blocks of trials interaction: F(3,81)
⫽ 5.71, p ⫽ 0.001). Indeed,
CaMKII␣Nampt ⫺ / ⫺ mice exhibited significantly greater path lengths relative to the control group during blocks 2–4 (pairwise
comparisons, p ⬍ 0.003). However, both
CaMKII␣Nampt ⫺ / ⫺ and control mice
showed a significant decrease in path length,
or improved performance, from block 1 to
block 4 (F(1,27) ⫽ 11.93, p ⫽ 0.002; and F(1,27)
⫽ 72.11, p ⬍ 0.00005, respectively), suggesting that some cued learning occurred
even in CaMKII␣Nampt ⫺ / ⫺ mice.
CaMKII␣Nampt ⫺ / ⫺ mice also exhibited significantly slower swimming speeds on average
across blocks of trials relative to control mice
(Figure 7B; 22% decrease; rmANOVA, genotype effect: F(1,27) ⫽ 46.21, p ⬍ 0.00005) and
for each block of trials (pairwise comparisons,
p ⬍ 0.0002). Because escape latency is directly
affected and confounded by differences in
swimming speeds, the significantly slower
swimming speeds in CaMKII␣Nampt ⫺ / ⫺
mice make escape latency an inappropriate
variable to assess performance. Therefore, the
latency data are not presented here. No significant effects involving sex were found during
the cued trials.
During acquisition training in the
place (spatial learning) condition of the
MWM, performance differences between
the groups became even greater. Across all
trial blocks, CaMKII␣Nampt ⫺ / ⫺ mice
Figure 7. CaMKII␣Nampt ⫺ / ⫺ mice show impairments in hippocampal-dependent learning and memory, but not LTP, at 2–3 showed much longer path lengths than
months of age. A–F, Evaluation of CaMKII␣Nampt ⫺ / ⫺ mice (n ⫽ 15) and control mice (n ⫽ 16) on the MWM. During both the control mice (Figure 7C; rmANOVAs, gecued (A) and place (C) conditions of the MWM, CaMKII␣Nampt ⫺ / ⫺ mice exhibited significantly longer path lengths to find the notype F(1,27) ⫽ 72.16, p ⬍ 0.00005; genoplatform relative to control mice. The swimming speed of CaMKII␣Nampt ⫺ / ⫺ mice was significantly lower than control mice in type ⫻ blocks of trials interaction F(4,108)
during acquisition of the cued (B) and the place (D) conditions of the MWM. During the probe condition of the MWM, ⫽ 3.11, p ⫽ 0.034). The performance of
CaMKII␣Nampt ⫺ / ⫺ mice exhibited significantly fewer platform crossings (E) and less time (F ) in the target quadrant relative to CaMKII␣Nampt ⫺ / ⫺ mice was significontrol mice. G, CaMKII␣Nampt ⫺ / ⫺ mice (n ⫽ 7) and control mice (n ⫽ 6) exhibit similar LTP at P60. H, Representative fEPSP cantly impaired for blocks 2– 4 (pairwise
traces for CaMKII␣Nampt ⫺ / ⫺ mice (top) and control mice (bottom). Calibration: 1 mV, 5 ms. Data are presented as mean ⫾ SEM. comparisons, beyond Bonferroni correc*p ⬍ 0.05; **p ⬍ 0.01; ***p ⬍ 0.001.
tion, p ⬍ 0.00005), whereas large differences were also observed for block 1
19.82, p ⫽ 0.0001) than controls (Fig. 6I–K ). These results
(F(1,27) ⫽ 6.71, p ⫽ 0.015). Specifically, CaMKII␣Nampt ⫺ / ⫺
mice initially showed a 1.5-fold longer path length in block 1 that
suggest that CaMKII␣Nampt ⫺ / ⫺ mice have mild sensorimotor
impairments in terms of speed to movement, coordination beincreased to 4.2-fold in block 5 (F(1,27) ⫽ 9.58, p ⫽ 0.005, and
F(1,27) ⫽ 19.18, p ⫽ 0.0002, respectively). However, as in the cued
tween the forelimbs and hindlimbs, and balance compared with
trials, both groups showed some evidence of spatial learning,
control mice.
although the performance of control mice was far superior.
Again, as in the cued trials, the CaMKII␣Nampt ⫺ / ⫺ mice also
CaMKII␣Nampt ⴚ / ⴚ mice show impaired spatial cognition in
the MWM
exhibited significantly decreased swimming speeds (Figure 7D;
To assess spatial learning and memory, we next evaluated
18% decrease, genotype effect: F(1,27) ⫽ 14.93, p ⫽ 0.0006), although this was dependent on the blocks of trials (genotype ⫻
CaMKII␣Nampt ⫺ / ⫺ and control mice on the MWM. In the cued
trials of the MWM, CaMKII␣Nampt ⫺ / ⫺ and control mice iniblocks of trials interaction: F(4,108) ⫽ 2.79, p ⫽ 0.030).
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CaMKII␣Nampt ⫺ / ⫺ mice swam significantly slower than control mice for
blocks 1–3 (pairwise comparisons, p ⬍
0.008), although differences were also observed during block 4 (pairwise comparison, p ⫽ 0.015). Consistent with the poor
acquisition performance during the place trials, CaMKII␣Nampt ⫺ / ⫺ mice also exhibited retention deficits during the probe
trial in terms of platform crossings (Figure 7E; genotype effect: F(1,27) ⫽ 20.89,
p ⫽ 0.0001) and time spent in the target
quadrant (Figure 7F; genotype effect:
F(1,27) ⫽ 19.04. p ⫽ 0.0002). Importantly,
control mice showed a spatial bias for the
target quadrant by spending significantly
more in that quadrant versus the times
spent in each of the other quadrants ( p ⬍
0.00005), whereas CaMKII␣Nampt ⫺ / ⫺
mice showed no such bias. Similar to the
results from the cued condition of the
MWM, no effects involving sex were
found for any of the variables from the
place or probe trials.
Based on the performance deficits exhib- Figure 8. CaMKII␣Nampt ⫺ / ⫺ mice show impairments in nonspatial hippocampal-dependent learning and memory at 2–3
ited by CaMKII␣Nampt ⫺ / ⫺ mice during months of age. A–D, Evaluation of fear conditioning in CaMKII␣Nampt ⫺ / ⫺ mice (n ⫽ 15) and control mice (n ⫽ 16). A, On day
the cued trials, we investigated the possi- 1, mice were subjected to T/S preconditioning. CaMKII␣Nampt ⫺ / ⫺ mice froze significantly less than control mice both during
2, mice were placed in the same chamber used for the T/S
bility that CaMKII␣Nampt ⫺ / ⫺ mice may baseline measurements and in response to the T/S stimuli. B, On⫺ day
/⫺
mice froze significantly less than control mice. C, Both
have had visual impairments that com- preconditioning⫺to/ ⫺evaluate contextual fear. CaMKII␣Nampt
CaMKII
␣
Nampt
and
control
mice
froze
significantly
more
during
the first 2 min of the contextual fear conditioning test (day
promised their ability to see proximal and
2) than in the first 2 min of baseline measurements taken during preconditioning (day 1). D, On day 3, mice were placed in a new
distal cues during MWM testing. Howchamber and the auditory tone stimulus was presented again to evaluate cued fear. Relative to control mice, CaMKII␣Nampt ⫺ / ⫺
ever, imaging their retinas revealed no mice froze significantly less both before and in response to the tone stimulus. Data are presented as mean ⫾ SEM. *p ⬍ 0.05;
gross defects relative to controls (data not **p ⬍ 0.01; ***p ⬍ 0.001.
shown). In addition, assessment of visual
acuity (grating) thresholds by quantifydent on the minutes of the test and sex (rmANOVAs, genotype
ing optokinetic tracking behavior and evaluation of the phoeffect: F(1,27) ⫽ 41.02, p ⬍ 0.00005; genotype ⫻ sex: F(1,27) ⫽
topic and scotopic waves by electroretinography did not reveal
4.27, p ⫽ 0.048; genotype by minutes: F(2,54) ⫽ 11.22, p ⫽
any differences between CaMKII␣Nampt ⫺ / ⫺ and control mice
0.0001). Control mice also froze significantly more often than
(data not shown).
CaMKII␣Nampt ⫺ / ⫺ mice during each minute of the tone/
Given the major impairments in spatial learning and memory
shock
(T/S) training (pairwise comparisons, p ⬍ 0.003). On
that CaMKII␣Nampt ⫺ / ⫺ mice displayed in all conditions of the
average, across minutes during the T/S training, the freezing
MWM, we suspected that there would be accompanying impairlevels of male and female CaMKII␣Nampt ⫺ / ⫺ mice were sigments in hippocampal synaptic plasticity. Using a half maximal
nificantly lower than their respective controls (genotype ⫻
fEPSP stimulus, we assessed LTP in P60 mice. To our surprise,
sex: F(1,27) ⫽ 10.90, p ⫽ 0.003; genotype ⫻ sex: F(1,27) ⫽ 32.77,
LTP in response to a single 100 Hz ⫻ 1 s HFS was not significantly
p
⬍ 0.00005, respectively).
different between groups (Fig. 7G). In control mice, HFS resulted
During the first 2 min of the contextual fear test conducted
in an increase in fEPSP slopes that was 189.5 ⫾ 23.1% of baseline
on
day 2, CaMKII␣Nampt ⫺ / ⫺ and control mice exhibited
⫺/⫺
measured 60 min after HFS. In CaMKII␣Nampt
mice, the
similar levels of freezing. However, the freezing levels in
fEPSP slopes were 165.0 ⫾ 18.5% of baseline (Fig. 7H; Student’s
CaMKII␣Nampt ⫺ / ⫺ mice subsequently dropped precipitously,
t test, p ⫽ 0.43, n ⫽ 5).
whereas the levels of control mice remained the same or slightly
increased across the test session, resulting in large differences
CaMKII␣Nampt ⴚ / ⴚ mice perform abnormally on the
between the groups for minutes 5– 8 (Figure 8B; rmANOVAs,
conditioned fear test
genotype effect: F(1,27) ⫽ 5.91, p ⫽ 0.022; genotype ⫻ minutes
With these major spatial learning and memory deficits, we next
⫺/⫺
interaction:
F(7,189) ⫽ 3.68, p ⫽ 0.014). Specifically, the freezing
␣
Nampt
addressed the possibility that CaMKII
mice also had
levels of the control mice were significantly greater than those of
cognitive deficits in nonspatial forms of learning and memory by
CaMKII␣Nampt ⫺ / ⫺ mice for minutes 5– 8 (pairwise comparievaluating the mice on the conditioned fear test. Analysis of the
sons,
p ⬍ 0.0005). To assess levels of conditioning produced by
baseline freezing data collected during the first 2 min of day 1 of
the
training
on day 1, we also conducted an additional analysis
conditioned fear testing did not reveal any significant effects incomparing the average freezing levels during the 2 min baseline
volving genotype or sex (Fig. 8A). In contrast, the freezing data
on day 1 with the average freezing levels quantified during the
during the training trials when a tone (CS) was paired with a foot
first 2 min of contextual fear testing on day 2 (Fig. 8C). These first
shock (US) on day 1 revealed significantly higher levels of
2 min on day 1 and day 2 were significantly different from each
freezing in control mice, although this was somewhat depen-
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other (averaged trials: F(1,27) ⫽ 26.50, p ⬍ 0.00005). However,
control and CaMKII␣Nampt ⫺ / ⫺ mice each showed significantly
increased freezing levels across the two test days (F(1,27) ⫽ 11.42,
p ⫽ 0.002, and F(1,27) ⫽ 15.28, p ⫽ 0.006, respectively), suggesting
that equivalent levels of conditioning occurred in both groups.
This is an interesting finding considering the large differences
that were observed between the groups during the T/S training
on day 1. It may be that the two groups showed approximately
equivalent degrees of contextual fear conditioning, but the
precipitous drop in freezing of CaMKII␣Nampt ⫺ / ⫺ mice reflected their difficulty in maintaining high levels of freezing given
their proclivity toward hyperactivity.
Surprisingly, during the altered context baseline testing on day 3
(minutes 1–2), the freezing levels of CaMKII␣Nampt ⫺ / ⫺ mice were
significantly higher than those of controls (Figure 8D; genotype
effect: F(1,27) ⫽ 5.03, p ⫽ 0.033), although the magnitude of differences were similar for minutes 1 ( p ⫽ 0.045) and 2 ( p ⫽
0.044). In contrast to the altered context baseline period, control mice exhibited greatly increased freezing levels relative to
the CaMKII␣Nampt ⫺ / ⫺ mice during the auditory cue test. These
differences became less prominent as the mice habituated to the tone
over the test session (rmANOVAs, genotype effect: F(1,27) ⫽ 9.47,
p ⫽ 0.005; genotype by minutes interaction: F(7,189) ⫽ 2.85, p ⫽
0.012). Differences were significant beyond Bonferonni correction ( p ⫽ 0.05/8 ⫽ 0.0063) during minute 3 ( p ⬍ 0.00005),
although large differences were also observed during minutes 4
( p ⫽ 0.009), 5 ( p ⫽ 0.017), 6 ( p ⫽ 0.026), and 7 ( p ⫽ 0.018).
There were no significant effects involving sex (rmANOVAs) for
any of the data from the contextual fear test (day 2) or the altered
context baseline or auditory cue test (day 3).
Given this impressive lack of freezing, we wondered whether
CaMKII␣Nampt ⫺ / ⫺ mice were able to feel the shock and hear
the tone. Therefore, after completion of the conditioned fear testing, we also evaluated the mice for their sensitivity to shock.
However, the shock sensitivity of control and CaMKII␣Nampt ⫺ / ⫺
mice did not reveal any significant differences between groups with
regard to the levels of shock that elicited flinching, vocalizing, or
running (data not shown). Thus, the differences in performance
levels between the two groups during the contextual fear and
auditory cue tests were not likely due to differences in shock
sensitivity. We also confirmed that none of the control or
CaMKII␣Nampt ⫺ / ⫺ mice was deaf or severely hearing impaired,
nor did any of them have sensorimotor deficits that prevented
them from displaying normal startle magnitudes in response to
loud tones (data not shown).
In summary, CaMKII␣Nampt ⫺ / ⫺ mice exhibited lower levels
of freezing compared with control mice during several phases of
the conditioned fear test, including T/S training, the middle and
later portions of the contextual fear test (day 2), and the early and
middle portions of the auditory cue test (day 3). Despite their
tendency to exhibit low levels of freezing, CaMKII␣Nampt ⫺ / ⫺
mice still showed some signs of contextual fear conditioning during the early period of the test session on day 2, when their freezing levels were equivalent to those of control mice.
CaMKII␣Nampt ⴚ / ⴚ mice exhibit decreased levels of anxietylike behaviors
CaMKII␣Nampt ⫺ / ⫺ mice showed some evidence of altered
emotionality, in terms of fear or anxiety-like behaviors, during
the 1 h locomotor activity test, as indexed by an increase in the
number of entries into, and the distance traveled in, the center of
the test arena compared with control mice (Fig. 6). However, this
interpretation was confounded by the hyperactivity of
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CaMKII␣Nampt ⫺ / ⫺ mice. Therefore, to determine whether
CaMKII␣Nampt ⫺ / ⫺ mice exhibit abnormal levels of anxietylike behaviors, we evaluated an independent cohort of naive
CaMKII␣Nampt ⫺ / ⫺ and control mice on the EPM. In the EPM,
CaMKII␣Nampt ⫺ / ⫺ mice displayed decreased levels of anxietylike behaviors relative to the control mice in terms of the classic
variables of entries made, time spent, and distance traveled in the
open arms (Fig. 9A–C). Specifically, CaMKII␣Nampt ⫺ / ⫺ mice
traveled significantly greater distances in the open arms compared with controls (Figure 9A; rmANOVA, genotype effect:
F(1,23) ⫽ 18.55, p ⫽ 0.0003; genotype ⫻ test day interaction:
F(2,46) ⫽ 6.78, p ⫽ 0.006). Significant differences were found on
test days 1 (pairwise comparison, p ⫽ 0.0001) and 3 (pairwise
comparison, p ⫽ 0.008), with large differences also observed on
day 2 ( p ⫽ 0.034). Similar results were found with regard to time
spent in the open arms (Figure 9B; genotype effect: F(1,23) ⫽
20.75, p ⫽ 0.0001), in which significant differences were observed
on test day 1 ( p ⬍ 0.00005), although differences were also observed on days 2 ( p ⫽ 0.033) and 3 ( p ⫽ 0.030). Last,
CaMKII␣Nampt ⫺ / ⫺ mice also made significantly more entries
into the open arms compared with control mice, with the largest
differences observed on test day 3 (Figure 9C; genotype effect:
F(1,23) ⫽ 9.84, p ⫽ 0.005).
We also analyzed the three aforementioned open arm variables after normalizing values to reflect percentages that were
calculated with reference to the totals measured in both sets of
arms to counteract any differences in activity that might affect
the results. Analyzing these data produced very similar results
to those described in the previous paragraph, providing additional evidence that the CaMKII␣Nampt ⫺ / ⫺ mice displayed
decreased levels of anxiety-like behaviors. Specifically,
CaMKII␣Nampt ⫺ / ⫺ mice traveled a significantly greater percentage of distance the open arms out of the total distance
traveled compared with control mice on average across the 3
testdays(rmANOVA,genotypeeffect: F(1,23) ⫽16.15, p⫽0.0005),with
significant differences on test day 1 (Fig. 9D; pairwise comparison, p ⫽
0.0002). Similarly, CaMKII␣Nampt ⫺ / ⫺ mice spent a significantly
greater percentage of time in the open arms relative to the total time
spent in all of the arms compared with control mice (Figure 9E;
genotype effects: F(1,23) ⫽ 18.07, p ⫽ 0.0003), with significant group
differences being observed for test day 1 (p ⫽ 0.0001) and large
differences found for days 2 (p ⫽ 0.046) and 3 (p ⫽ 0.027). Last,
CaMKII␣Nampt ⫺ / ⫺ mice had a significantly higher percentage of
entries made into the open arms out of the total number of arm
entries on average across test days compared with control mice (Figure 9F; genotype effect: F(1,23) ⫽ 8.44, p ⫽ 0.0008), with the largest
differences being observed on day 1 (p ⫽ 0.024).
Although CaMKII␣Nampt ⫺ / ⫺ mice traveled longer distances
in the open arms of the EPM than control mice, the two groups
did not differ in the distance traveled in the relatively safe confines of the closed arms (Fig. 9G). CaMKII␣Nampt ⫺ / ⫺ mice
actually traveled a significantly shorter distance in the center area
compared with control mice (genotype effect: F(1,23) ⫽ 8.04, p ⫽
0.009; genotype ⫻ test day interaction: F(2,46) ⫽ 8.78, p ⫽ 0.001),
with significant differences being found for day 1 ( p ⫽ 0.002) and
large differences observed for day 2 (Fig. 9H; p ⫽ 0.032). However, the two groups did not differ in the total distance traveled
throughout the EPM, thus providing additional evidence that
CaMKII␣Nampt ⫺ / ⫺ mice exhibit abnormally low levels of
anxiety-like behaviors that are not dependent on differences in
general ambulatory activity (Fig. 9I ). No significant overall
effects involving sex were found from any of the rmANOVAs
conducted on the above-mentioned EPM variables. In conclu-
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sion, CaMKII␣Nampt ⫺ / ⫺ mice exhibited decreased anxiety-like behaviors in
the EPM. Although the most parsimonious interpretation of the data is that
CaMKII␣Nampt ⫺ / ⫺ mice have lower
levels of an emotional state that may be
analogous to “anxiety,” their poor performance on the MWM raises the possibility that these mice may have a
diminished cognitive capacity to detect
threatening situations and thus do not
respond like control mice under such
circumstances.

Discussion
In this study, we tested the importance of
intracellular NAD ⫹ biosynthesis from
nicotinamide by generating mice lacking a
key NAD ⫹ biosynthetic enzyme, Nampt,
in forebrain excitatory neurons. We show
that CaMKII␣Nampt ⫺ / ⫺ mice develop
hippocampal and cortical atrophy, astrogliosis, microgliosis, and aberrant dendritic
morphology by 2–3 months of age. These
histological changes were associated with altered intrahippocampal connectivity and
abnormal behavior. Therefore, intracellular
Nampt-mediated NAD ⫹ biosynthesis is the
primary source of NAD ⫹ for forebrain excitatory neurons and is critical for neuronal
function and survival.
Figure 9. CaMKII␣Nampt ⫺ / ⫺ mice have impaired ability to exhibit anxiety. A–I, Evaluation of CaMKII␣Nampt ⫺ / ⫺ mice
Consistent with the established fea- (n ⫽ 12) and control mice (n ⫽ 15) on the EPM. CaMKII␣Nampt ⫺ / ⫺ mice exhibited increased open arm distance (A), open arm
tures of CaMKII␣Cre driver mice (Tsien time (B), and open arm entries (C) relative to control mice, which corresponded to increased percentage distance traveled in open
et al., 1996; Luikart et al., 2005; Monteggia arms (D), time spent in open arms (E), and entries into open arms (F ) relative to control mice. CaMKII␣Nampt ⫺ / ⫺ mice also
et al., 2007; Wang et al., 2011a), we ob- displayed similar closed arm distance (G) as control mice, but decreased center distance (H ), particularly on the first day of training.
served a large reduction in Nampt ⫹ cells, CaMKII␣Nampt ⫺ / ⫺ mice showed similar total arm distance (I ) as control mice. Data are presented as mean ⫾ SEM. *p ⬍ 0.05;
particularly in the hippocampal CA1 sub- **p ⬍ 0.01; ***p ⬍ 0.001.
region, and a significant reduction in total
hippocampal NAD ⫹ levels. Nonetheless,
Somjen, 1985; Young and Somjen, 1992; Mitani et al., 1993),
CaMKII␣Nampt ⫺ / ⫺ mice also displayed remarkable hippocamneurotransmitter imbalances (Konnerth and Heinemann, 1983),
pal changes without obvious apoptosis, necrosis, or autophagy.
ionic imbalances (Balestrino et al., 1986), glycolytic blockade
An intriguing change in CaMKII␣Nampt ⫺ / ⫺ mice is their atro(Tekkök and Krnjević, 1995), or neuronal loss (Patterson et al.,
phied and swollen Map2 ⫹ dendrites, indicating altered neuronal
1996). Importantly, excitotoxicity and glycolytic blockade inconnectivity. Supporting this notion, electrophysiological assesscrease presynaptic volley amplitude by increasing sodium entry
ments revealed changes in the relationship between inputs and
and facilitating axonal excitability (Tekkök and Krnjević, 1996;
outputs in CA1. Namely, CaMKII␣Nampt ⫺ / ⫺ mice required
Suárez et al., 2005; Winegar and MacIver, 2006). Therefore, it is
larger presynaptic volleys to evoke maximal population spike firpossible that CaMKII␣Nampt ⫺ / ⫺ hippocampal neurons have an
ing. Presynaptic volleys represent the summed discharge of acaltered firing threshold.
tion potentials from afferent axons that arrive in CA1 after
With such profound histological and electrophysiological abSchaffer collateral pathway stimulation. Therefore, larger presynnormalities, we predicted that CaMKII␣Nampt ⫺ / ⫺ mice would
aptic volleys suggest the need to recruit more presynaptic neushow behavioral changes associated with altered CA1 function,
rons and perhaps altered action potential initiation, propagation,
including hyperactivity, reduced anxiety-like behaviors, and imand/or amplitude (Soleng et al., 2003; Meeks and Mennerick,
paired cognition (Fanselow, 2000; Kubik et al., 2007; Barkus et
2004). In CaMKII␣Nampt ⫺ / ⫺ mice, Schaffer collateral pathway
al., 2010; Langston et al., 2010). Indeed, CaMKII␣Nampt ⫺ / ⫺
stimulation triggered synaptic responses (fEPSPs) that promoted
mice showed robust changes in all of the above. Most strikingly,
spike firing. Moreover, CA1 glutamatergic synapses, once actiCaMKII␣Nampt ⫺ / ⫺ mice required longer escape path lengths to
vated, could generate and sustain LTP. The normal fEPSPs obfind the platform in both the cued and place (spatial learning)
served in CaMKII␣Nampt ⫺ / ⫺ mice indicate that basal synaptic
conditions of the MWM. Although the performance of
transmission, presynaptic neuron transmitter release, and postCaMKII␣Nampt ⫺ / ⫺ mice was substantially inferior to control
synaptic neuronal responses are intact and not a primary defect,
mice, they nevertheless showed improvement over time, suggestalthough more systematic evaluation could uncover changes in
ing some spatial learning. However, the lack of retention disthese parameters as well. Such defects in hippocampal function
played by CaMKII␣Nampt ⫺ / ⫺ mice during the probe trial
implies that spatial learning and/or retention was minimal. This
have not been observed in other models of disease (Schiff and
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impairment in the MWM performance of CaMKII␣Nampt ⫺ / ⫺
mice is particularly surprising in light of their intact LTP. Indeed,
previous work has strongly correlated MWM performance (Jeffery and Morris, 1993; Tombaugh et al., 2002) and expression of
immediate early genes including Egr1 (Davis et al., 2003) and Arc
(Kubik et al., 2007) with LTP. Therefore, CaMKII␣Nampt ⫺ / ⫺
mice present an interesting discrepancy in functional, electrophysiological, and histopathological phenotypes.
Conditioned fear testing revealed that cognitive deficits in
CaMKII␣Nampt ⫺ / ⫺ mice extend to Pavlovian conditioning involving nonspatial learning and memory. During the T/S training, CaMKII␣Nampt ⫺ / ⫺ mice showed much less freezing
behavior than control mice, suggesting that the foot shocks produced less fear in these mice or that their hyperactivity made it
difficult for them to remain motionless. CaMKII␣Nampt ⫺ / ⫺
mice displayed similar levels of freezing as control mice during
the first 2 min of the contextual fear testing, but after these first 2
min, and during the auditory cue testing, CaMKII␣Nampt ⫺ / ⫺
mice showed little freezing behavior. Therefore, the T/S training
may have produced some conditioned or generalized fear in
CaMKII␣Nampt ⫺ / ⫺ mice, the behavioral expression of which
was compromised by hyperactivity. It will be interesting to evaluate aversive conditioning in CaMKII␣Nampt ⫺ / ⫺ mice by procedures that do not use freezing as a primary outcome.
Our results suggest that CaMKII␣Nampt ⫺ / ⫺ mice have
cognitive deficits that are coupled with hyperactivity and abnormally low levels of anxiety-like behavior. Importantly, our
findings that CaMKII␣Nampt ⫺ / ⫺ mice were more active than
control mice in the threatening open arms of the EPM suggest
that they may exhibit abnormal hyperactivity in environments
that contain aversive stimuli. Additional studies are needed to
determine whether the reduced anxiety-like behaviors in
CaMKII␣Nampt ⫺ / ⫺ mice represent altered emotionality or an
inability to perceive danger. It is also interesting that
CaMKII␣Nampt ⫺ / ⫺ male mice showed more extensive body
weight and activity phenotypes than CaMKII␣Nampt ⫺ / ⫺ female
mice, considering that reducing Nampt activity in peripheral tissues generates stronger phenotypes in female mice than male
mice (Revollo et al., 2007; Ramsey et al., 2008).
Although the hyperactivity, impaired learning and memory,
and reduced levels of anxiety-like behaviors observed in
CaMKII␣Nampt ⫺ / ⫺ mice correspond nicely with a loss of CA1
functionality, their impaired performance on the auditory cue
testing does not (Fanselow, 2000; Kubik et al., 2007; Barkus et al.,
2010; Langston et al., 2010). One explanation for this discrepancy
is that the CA1 atrophy in CaMKII␣Nampt ⫺ / ⫺ mice disrupted
anatomical connections between CA1 and other brain areas, including the entorhinal cortex, DG, CA3, and subiculum areas,
and thereby impaired their functions (Cantó et al., 2008; Langston et al., 2010; Piskorowski and Chevaleyre, 2012). Indeed, multiple regions of the cortex have been implicated in fear responses
(Casey et al., 2013). It is also possible that the poor performance
of CaMKII␣Nampt ⫺ / ⫺ mice on the auditory cue testing is the
result of their hyperactivity. However, additional control groups
(e.g., shock alone or “unpairing” of the tone and shock) are
needed to determine whether auditory cue performance impairments result from “true conditioning” or other processes such as
sensitization. Given the CA1 pathology in CaMKII␣Nampt ⫺ / ⫺
mice, we included the auditory cue testing as a control for the
specificity of the contextual fear performance deficit.
Importantly, the collective cellular, physiological, and behavioral phenotypes displayed by CaMKII␣Nampt ⫺ / ⫺ mice
are specific to loss of Nampt-mediated NAD ⫹ biosynthesis.

J. Neurosci., April 23, 2014 • 34(17):5800 –5815 • 5813

CaMKII␣Cre-driven deletion of multiple other factors produces
forebrain degeneration, but with profoundly different chronologies, pathways of cell death, and behavioral effects from those we
observed (Sörensen et al., 2001; Tabuchi et al., 2009; Hébert et al.,
2010). Therefore, the phenotypes of CaMKII␣Nampt ⫺ / ⫺ mice
cannot be equated with simple regional death and dysfunction.
Instead, the complex array of phenotypes in CaMKII␣Nampt ⫺ / ⫺
mice, in the absence of major health or sensory impairments, potentially place CaMKII␣Nampt ⫺ / ⫺ mice as a novel model of CA1
dysfunction. Such a model has considerable value because CA1 sustains more damage than other hippocampal subregions in many
prevalent diseases and conditions, including ischemia (Calabresi et
al., 2003; Crepel et al., 2003; Nikonenko et al., 2009), excitotoxicity
(Stanika et al., 2010), status epilepticus (do Nascimento et al., 2012),
and Alzheimer’s disease (Apostolova et al., 2010; Costafreda et al.,
2011; Padurariu et al., 2012).
Currently, the mechanism(s) downstream of Nampt is unknown. Although NAD ⫹ is best known for redox recycling, it
also functions as a substrate for several families of enzymes, including sirtuins (e.g., Sirt1), PARPs (e.g., Parp1), and CD38/157
cADP-ribose synthases (Houtkooper et al., 2010; Stein and Imai,
2012). However, the CaMKII␣Nampt ⫺ / ⫺ phenotypes do not appear to result from loss of Sirt1 or Parp1 function. CaMKII␣driven loss of Sirt1 does not generate overt CA1 and cortical
atrophy (data not shown). Moreover, both deletion of Sirt1 (Gao
et al., 2010; Michán et al., 2010) and inhibition of Parp1 (FontánLozano et al., 2010) impair LTP. Furthermore, neither Sirt1 (Gao
et al., 2010; Michán et al., 2010; Wu et al., 2011; Gräff et al., 2013)
nor Parp1 (Fontán-Lozano et al., 2010) conclusively affect activity. Conversely, it is plausible that loss of CD38/157 activity contributes to CaMKII␣Nampt ⫺ / ⫺ phenotypes because CD38/157
generates the second messenger cADP-ribose, which contributes
to calcium mobilization via ryanodine receptors (Sauve, 2008;
Young and Kirkland, 2008; Houtkooper et al., 2010).
There is clearly an impetus to investigate novel molecules involved in CA1 function. Cerebral ischemia, childhood-onset psychiatric disorders, and dementia are major causes of death and
disability (Nikonenko et al., 2009; Frisardi et al., 2010; Robertson
and Feng, 2011; Sartori et al., 2011; Kvajo et al., 2012). Establishing animal models is essential for understanding the pathology of
these diseases, yet this is difficult because of their multifaceted
environmental and genetic causes (Kvajo et al., 2012). To our
knowledge, this is the first study to show that forebrain excitatory
neuron ablation of Nampt has serious repercussions for neuronal
function and survival, which affects associated cognitive capabilities
and behaviors. Further investigation of CaMKII␣Nampt ⫺ / ⫺ mice
should provide valuable information regarding CA1 and cortical
neuron vulnerability, function, and properties.
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(2005) Presynaptic NMDA autoreceptors facilitate axon excitability: a
new molecular target for the anticonvulsant gabapentin. Eur J Neurosci
21:197–209. CrossRef Medline
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